1ysx: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="1ysx" size="450" color="white" frame="true" align="right" spinBox="true" caption="1ysx" /> '''Solution structure of domain 3 from human s... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1ysx.gif|left|200px]]<br /> | [[Image:1ysx.gif|left|200px]]<br /><applet load="1ysx" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="1ysx" size=" | |||
caption="1ysx" /> | caption="1ysx" /> | ||
'''Solution structure of domain 3 from human serum albumin complexed to an anti-apoptotic ligand directed against Bcl-xL and Bcl-2'''<br /> | '''Solution structure of domain 3 from human serum albumin complexed to an anti-apoptotic ligand directed against Bcl-xL and Bcl-2'''<br /> | ||
==Overview== | ==Overview== | ||
Proteins in the Bcl-2 family are central regulators of programmed cell | Proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-X(L) and Bcl-2, are overexpressed in many cancers and contribute to tumour initiation, progression and resistance to therapy. Bcl-X(L) expression correlates with chemo-resistance of tumour cell lines, and reductions in Bcl-2 increase sensitivity to anticancer drugs and enhance in vivo survival. The development of inhibitors of these proteins as potential anti-cancer therapeutics has been previously explored, but obtaining potent small-molecule inhibitors has proved difficult owing to the necessity of targeting a protein-protein interaction. Here, using nuclear magnetic resonance (NMR)-based screening, parallel synthesis and structure-based design, we have discovered ABT-737, a small-molecule inhibitor of the anti-apoptotic proteins Bcl-2, Bcl-X(L) and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compounds. Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation. ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumours, and produces cures in a high percentage of the mice. | ||
==Disease== | ==Disease== | ||
| Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
1YSX is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with 4EB as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | 1YSX is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=4EB:'>4EB</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1YSX OCA]. | ||
==Reference== | ==Reference== | ||
| Line 17: | Line 16: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Armstrong, R | [[Category: Armstrong, R C.]] | ||
[[Category: Augeri, D | [[Category: Augeri, D J.]] | ||
[[Category: Belli, B | [[Category: Belli, B A.]] | ||
[[Category: Bruncko, M.]] | [[Category: Bruncko, M.]] | ||
[[Category: Connor, J | [[Category: Connor, J M.O.]] | ||
[[Category: Deckwerth, T | [[Category: Deckwerth, T L.]] | ||
[[Category: Dinges, J.]] | [[Category: Dinges, J.]] | ||
[[Category: Elmore, S | [[Category: Elmore, S W.]] | ||
[[Category: Fesik, S | [[Category: Fesik, S W.]] | ||
[[Category: Hajduk, P | [[Category: Hajduk, P J.]] | ||
[[Category: Joseph, M | [[Category: Joseph, M K.]] | ||
[[Category: Kitada, S.]] | [[Category: Kitada, S.]] | ||
[[Category: Korsmeyer, S | [[Category: Korsmeyer, S J.]] | ||
[[Category: Kunzer, A | [[Category: Kunzer, A R.]] | ||
[[Category: Letai, A.]] | [[Category: Letai, A.]] | ||
[[Category: Li, C.]] | [[Category: Li, C.]] | ||
[[Category: Mitten, M | [[Category: Mitten, M J.]] | ||
[[Category: Nettesheim, D | [[Category: Nettesheim, D G.]] | ||
[[Category: Ng, S.]] | [[Category: Ng, S.]] | ||
[[Category: Nimmer, P | [[Category: Nimmer, P M.]] | ||
[[Category: Oleksijew, A.]] | [[Category: Oleksijew, A.]] | ||
[[Category: Oltersdorf, T.]] | [[Category: Oltersdorf, T.]] | ||
[[Category: Petros, A | [[Category: Petros, A M.]] | ||
[[Category: Reed, J | [[Category: Reed, J C.]] | ||
[[Category: Rosenberg, S | [[Category: Rosenberg, S H.]] | ||
[[Category: Shen, W.]] | [[Category: Shen, W.]] | ||
[[Category: Shoemaker, A | [[Category: Shoemaker, A R.]] | ||
[[Category: Tahir, S | [[Category: Tahir, S K.]] | ||
[[Category: Thompson, C | [[Category: Thompson, C B.]] | ||
[[Category: Tomaselli, K | [[Category: Tomaselli, K J.]] | ||
[[Category: Wang, B.]] | [[Category: Wang, B.]] | ||
[[Category: Wendt, M | [[Category: Wendt, M D.]] | ||
[[Category: Zhang, H.]] | [[Category: Zhang, H.]] | ||
[[Category: 4EB]] | [[Category: 4EB]] | ||
[[Category: complex]] | [[Category: complex]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:08:42 2008'' | ||